August J. Moretti - Dec 21, 2022 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Chief Financial Officer
Signature
/s/ August J. Moretti
Stock symbol
FDMT
Transactions as of
Dec 21, 2022
Transactions value $
$28,230
Form type
4
Date filed
12/22/2022, 05:51 PM
Previous filing
Sep 6, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FDMT Common Stock Options Exercise $28.2K +3K +83.45% $9.41 6.6K Dec 21, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Options Exercise $0 -3K -1.34% $0.00 220K Dec 21, 2022 Common Stock 3K $9.41 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects 1,595 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Rule 16b-3.
F2 25% of the shares subject to the option vest on the first anniversary measured from January 7, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.